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Abstract SPECT myocardial perfusion imaging
(MPI) is commonly used for comprehensive interpre-
tation of metabolic PET FDG imaging in ischemic
dysfunctional myocardium. We evaluated the differ-
ence in scan interpretation introduced by CT attenu-
ation correction (CTAC) of SPECT MPI in patients
undergoing viability characterization by 99mTc
SPECT MPI/PET FDG. In 46 consecutive patients
(mean age 64, range 36–83 years) with dysfunctional
myocardium, we analyzed viability from combined
SPECT MPI and PET FDG scanning without atten-
uation correction (NC) and with CTAC for SPECT
MPI. FDG uptake was classified in groups of percent
uptake using the segment with maximum tracer in
SPECT perfusion uptake as reference. Viability
patterns were categorized as normal, mismatch, mild
match and scar by relative comparison of SPECT and
PET. Applying CTAC introduced a different refer-
ence segment for the normalization of PET FDG study
in 57% of cases. As a result, the flow-metabolism
pattern changed in 28% of segments, yielding a
normal, mismatch, mild match and scar pattern in 462,
150, 123, and 47 segments with NC and 553, 86, 108,
and 35 with CTAC, respectively (P = 0.001). Thus,
by introducing CTAC for SPECT MPI 25% of
segments originally classified as scar were reclassified
and the number of normal segments increased by
20%. Introducing CTAC decreased by 54% the
number of patients with possible indication for
revascularization, from 26/46 to 12/46 (P \ 0.001).
Different interpretation of myocardial viability can be
observed when using CTAC instead of NC SPECT
MPI as reference for PET FDG scans.
Keywords SPECT  CT attenuation correction 
Viability
Introduction
Due to the wide interindividual as well as regional
variations in myocardial glucose uptake, accurate
assessment of viability in ischemic dysfunctional left
ventricular segments by 18F-fluorodesoxyglucose
(FDG) requires normalization of FDG using myocar-
dial perfusion imaging (MPI) as relative standard of
reference. This is particularly true when the concept
of flow-metabolism ‘‘mismatch’’ is used where seg-
ments with decreased flow but preserved viability
reveal hibernating myocardium. Among different
techniques to evaluate myocardial perfusion, positron
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emission tomography (PET) is generally accepted as
gold standard, providing quantitative measures of
flow [1]. However, its availability has remained
confined to centers with on-site cyclotron or with
high patient volume throughput justifying the use of
82Rb-generators [2]. By contrast, single photon
emission computer tomography (SPECT) MPI is
widely available and compares well with PET MPI in
association with metabolic PET FDG for the predic-
tion of functional recovery. The fact that SPECT MPI
is affected by non-uniform soft tissue attenuation has
for long time been a caveat and a disadvantage
compared to PET. Over the past years, introduction of
methods for attenuation correction (AC) have sub-
stantially improved the accuracy of SPECT MPI,
particularly when using computer tomography (CT)
to obtain attenuation maps [3]. The added value of
CTAC on the accuracy of SPECT MPI has been well
established [4]. However, its impact on the interpre-
tation of metabolic activity and hence on the final
evaluation of viability studies, when using SPECT
MPI as reference for FDG normalization, has not
been systematically assessed. In view of the growing
burden of coronary artery disease (CAD) related
cardiac failure and the increased availability and use
of SPECT devices with CTAC for MPI studies, a
systematic evaluation of the impact of CTAC on
viability interpretation seems pertinent. As prognostic
data regarding appreciation of cardiac viability by
nuclear techniques greatly relies on studies with no
correction of attenuation (NC), our objective was to
compare SPECT MPI with CTAC versus SPECT
MPI without AC in the evaluation of metabolic
activity assessed by PET FDG and the impact of
introducing CTAC on the final definition of viability
pattern.
Materials and methods
Patient selection
The study population consisted in 50 consecutive
patients with angiographically proven CAD and
decreased global left ventricular ejection fraction
referred for an evaluation of viability by SPECT MPI/
PET FDG. The study was approved by the local
ethics committee and patients gave their written
informed consent.
CT imaging for attenuation correction
Attenuation correction scan covering the entire heart
using prospectively ECG-triggered sequential images
at 70% of the R-R interval was obtained on a
LightSPeed VCT scanner (General Electric Medical
Systems, Milwaukee, WI, USA) during deep inspi-
ration. 2.5 mm section thickness, a 0.35 s gantry
rotation time at 120 kV and 200–250 mA, depending
on the patient’s size were used as scanning param-
eters. CT images were reconstructed at a 5.0 mm
section thickness by using a reconstruction algorithm
with a 512 9 512 matrix and a full-chest-size
adapted FOV of 50 9 50 cm. These reconstructed
images were used both for attenuation correction and
for coronary calcium scoring as previously described
[5].
Myocardial perfusion image acquisition
and processing
All patients underwent a 1-day ECG-gated adenosine
stress/rest or rest-only protocol. Post-stress image
acquisition was performed 90 min after administra-
tion of 250–350 MBq of 99mTc-tetrofosmin injected
3 min into the pharmacologic stress. Rest images
acquisition was performed 4 h later after administra-
tion of 750–1050 MBq of 99mTc-tetrofosmin. For
rest-only protocol, images were acquired 90 min after
administration of 250–350 MBq of 99mTc-tetrofos-
min. Gated SPECT studies were performed with a
dual-head detector camera (Millenium VG and
Hawkeye; GE Healthcare) as previously described
[6]: a low-energy, high-resolution collimator; a 20%
symmetric window at 140 keV; a 64 9 64 matrix; an
elliptic orbit with step-and shoot acquisition at 3
intervals over 180; and a 20 s dwell time per stop.
Acquisitions were gated at 16 frames per R-R cycle
with a 50% window of acceptance.
For all patients, the summed ungated SPECT
image set was reconstructed on a dedicated worksta-
tion (eNTEGRA or Xeleris; GE Medical systems,
Milwaukee, Wis) by using an iterative reconstruction
ordered-subset expectation maximization (OSEM,
with 2 iterations and 10 subsets) and with CTAC
correction. Polar maps of perfusion, wall motion, and
wall thickening were derived by using a commer-
cially available software package (Cedars QGS/QPS;
Cedars-Sinai Medical Center, Los Angeles, Calif).
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PET FDG image acquisition and processing
Myocardial viability testing was performed on a PET/
CT scanner using FDG after completing the SPECT
MPI. This sequence was chosen in order to avoid spill
over from high-energy photons of 18F during SPECT
acquisition. All patients were advised to fast for at least
6 h before the PET examination. The injection of
labelled FDG was performed after a standardized oral
glucose load [7]. Following injection of 250 MBq of
FDG, patients rested for about 1 h before image
acquisition. Images were acquired on a GE Advance
PET scanner or on a Discovery (LS/RX) PET/CT
scanner (both GE Healthcare, Miwaukee, Wis). CT
attenuation maps were used for AC as previously
reported [8]. Acquired images were reconstructed using
attenuation weighted-OSEM iterative reconstruction (2
iterations and 8 subsets). Fourier rebinning was used for
the reduction of 3D data set into 2D equivalent [9]. FDG
uptake polar maps were equally derived by using the
Cedars QPS/QGS software package.
SPECT MPI interpretation
All polar maps were arranged in 17 segments then
divided into coronary territories (LAD, left anterior
descending; CX, left circumflex; RCA, right coronary
artery) according to standard segmentation of left
ventricle acknowledged by ACC/AHA [10]. All MPI
scans were evaluated twice, i.e. NC and CTAC. A
segment with an average uptake in MPI below 70% and
below 50% of maximal uptake was classified as perfusion
defect and severe perfusion defect, respectively [11].
PET FDG scan interpretation
The segment with maximum uptake on MPI scan was
also considered to represent normal value for FDG
polar map and FDG segmental uptake on this
segment was set as 100% to normalize others
accordingly. All segments were categorized accord-
ing to the respective relative metabolic uptake into
group A–E (group A- 0–24% uptake; B- 25–49%; C-
50–74%; D- 75–99%, E- C100).
Interpretation of viability pattern
Viability was evaluated from integrating SPECT MPI
and PET FDG scan results. Myocardial segments
were categorized as normal (perfusion over 70% of
SPECT maximum uptake), mismatch (perfusion
\70% and difference between FDG and MPI
[20%), mild match (perfusion between 50 and
70% and difference between FDG and MPI uptake
\20%) and scar (perfusion \50% and difference
between FDG and MPI uptake \20%) as previously
proposed [12, 13]. Mismatch was considered to
indicate jeopardized but viable myocardium.
Correlative invasive coronary angiography (ICA)
Where available, results from recent ICA (less than
6 month) and gated SPECT were integrated in the
clinical evaluation of discordant cases. Coronary
luminal narrowing were described as non-significant
(\50% stenosis in diameter), intermediate (50–70%)
or severe stenosis ([70%).
Statistical analysis
Values were given as mean ± standard deviation
(SD). Bland–Altman limits of agreement and system-
atic bias were provided on the difference in tracer
uptake after the SPECT MPI. Data were compared for
difference in distribution and agreement using chi
square and kappa (j) statistics. We considered k values
of 0.4, of 0.4–0.75, and of [0.75 to represent poor,
moderate to good, and excellent agreement, respec-
tively. Mc Nemar test was used to compare difference
in evaluation of patients with preserved viability. A
two-tailed P value under 0.05 was judged significant.
Results
Of the 50 patients, 8 had diabetes mellitus. Four of
them presented an FDG study of poor quality with
unability to compute an activity polar map. They
were excluded from further analysis. The remaining
46 patients were considered for comparative study.
Baseline characteristics of the study population are
summarized in Table 1.
SPECT MPI
782 segments and 144 coronary territories were
amenable to analysis. When comparing 99mTc-tetro-
fosmin uptake from NC versus CTAC, Bland–Altman
Int J Cardiovasc Imaging (2011) 27:913–921 915
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limits of agreement and the mean difference in uptake
(CTAC minus NC) were comparable for LAD (-12
to 12%; 0.6%) and CX (-11 to 15%; 2.1%), but
markedly wider and the difference larger for RCA
territory (-12 to 25%; 5.9%). On the NC SPECT
study, the segment with maximum uptake was in the
CX (32/46) or the LAD (14/46) territory, while it was
located in CX (27/46), LAD (9/46) and RCA territory
(9/46) with CTAC SPECT. NC and CTAC study
agreed on the segment with maximum uptake in 20
patients (43%), while they differed on segments of
the same coronary region in 11 patients (24%) and of
another coronary region in 15 patients (33%) Fig. 1.
On NC SPECT MPI there were 320 segments with
less than 70% and 108 segments with less than 50%
tracer uptake. After CTAC there were 228 and 55
segments with less than 70 and 50% uptake, respec-
tively (P \ 0.001). Accordingly, agreement between
SPECT MPI with NC and after CTAC was moderate
(570/782; 73%, j = 0.47; 95%CI 0.409–0.531;
weighted j = 0.558).
PET FDG
Based on NC SPECT reference segments of maxi-
mum uptake, PET metabolic activity according to
group A, B, C, D, and E was found in 6, 57, 185, 298,
and 236 segments. After CTAC of SPECT the
respective numbers were 6, 58, 157, 295, and 266
(P = ns). The agreement in FDG classification
between NC and CTAC reference was good (79%;
j = 0.70, 95%CI 0.66–0.74; weighted j = 0.77).
Table 2 provides the classification of segments
with regard to FDG uptake according to the coronary
territory with NC and after CTAC. Within vessel
Table 1 Characteristics of the study population
Number of patients 46
Age, mean (range) 64 (36–83)
Gender, (F/M) 5/41
BMI, mean (SD) 26.3 (3.59)
Diabetes 9%
LVEF%, mean (SD) 33 ± 15.95
ECG
Normal 19%
LBBB 25%
Q waves 32%
Symptoms
Dyspnoea 64%
Typical chest pain 26%
Atypical chest pain 17%
History of CAD
Myocardial infarction 44%
PCI 62%
CABG 13%
BMI Body mass index (kg/m2), LVEF left ventricular ejection
fraction, LBBB left bundle branch block, CAD coronary artery
disease, PCI percutaneous coronary intervention, CABG
coronary artery bypass grafting
Fig. 1 Observed changes when using CTAC in the localisa-
tion of the segment with highest uptake on SPECT MPI (i.e.
the reference segment) used for the evaluation of FDG uptake
Table 2 Distribution of segments according to FDG uptake
Territory FDG uptake
A (%) B (%) C (%) D (%) E (%)
LAD
NC 1 8 23 41 27
CTAC 1 8 21 38 31
CX
NC 1 4 17 35 42
CTAC 1 5 13 31 49
RCA
NC 1 9 31 36 23
CTAC 1 9 25 43 21
Groups of FDG uptake: A (uptake 0–24%), B (uptake
25–49%), C (uptake 50–74%), D (uptake 75–99%), E
(uptake C100%), LAD left anterior descending artery, CX left
circumflex artery, RCA right coronary artery, NC no
attenuation correction, CTAC CT attenuation correction
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territories, there was no significant change from NC
to CTAC (P = ns). Consequently, there was a fairly
good agreement between NC and CTAC in the LAD
(77% of agreement; j = 0.685), as well as in the
LCX (71%, j = 0.6; 95%CI 0.518–0.683) and RCA
(75%, j = 0.662; 95%CI 0.585–0.739).
Flow-metabolism patterns
Using NC SPECT as reference there were 462, 150,
123, 47 segments with normal, mismatch, mild match
or scar pattern. The respective numbers after CTAC
were 553, 86, 108, 35 (P = 0.0001) Fig. 2. These
results were concordant in 566/782 segments (72%,
j = 0.485; 95%CI 0.427–0.544, weighted
j = 0.557) showing moderate agreement between
evaluation using NC versus CTAC SPECT MPI. In
fact, after introducing CTAC, 25% of segments
originally classified as scar were reclassified and the
number of normal segments increased by 20%. An
example of the changes in flow-metabolism pattern
introduced with the use of CTAC is given in Fig. 3.
The analysis in the LAD territory resulted in
normal, mismatch, mild match or scar pattern in 214,
43, 45, 20 segments with NC and 211, 45, 44, 22
segments with CTAC (P = ns). The respective
results in the CX territory were 170, 24, 29, 7
segments for NC and 190, 11, 27, 2 segments after
CTAC (P = ns). Finally, the respective numbers in
the RCA territory were 78, 83, 49, 20 for NC and
152, 30, 37, 11 segments after CTAC (P = 0.0001)
Table 3.
The agreement between NC and CTAC with
regard to viability patterns was good for the LAD
segments (266/322, 82%, j = 0.667; 95%CI
0.588–0.746, weighted j = 0.722), moderate for the
CX segments (188/230, 81%, j = 0.506; 95%CI
0.370–0.641, weighted j = 0.583) and fair for the
RCA segments (112/230, 48%, j = 0.257; 95%
C23.3I 0.163–0.350; weighted j = 0.320).
After complete evaluation using NC, 26/46 patients
presented 3 or more viable segments (which repre-
sents at least 18% of the left ventricle). 19/46 patients
presented 21 vessel territories with at least 3 viable
segments. These were within the LAD (n = 3), CX
(n = 3) and RCA (n = 15) vessel territories, respec-
tively. Of them, 2 patients had viable tissue in two
vessel territories while the 17 remaining had viable
tissue localized in one vessel territory.
By contrast, using CTAC there were 12/46 patients
with 3 or more viable segments and 10/46 patients
(P = 0.001). Eleven vessel territories presented at
least 3 viable segments within the LAD (n = 5), CX
(n = 2) and RCA (n = 4) patients territory. Of them,
1 patient had viable tissue in two vessel territories
and 9 in one vessel territory. As patients presenting at
least 3 viable or ischemic segments are generally
considered good candidates for revascularization,
introducing CTAC decreased the number of patients
with possible indication for revascularization by
54%, from 26/46 to 12/46 (P \ 0.001).
Correlative ICA
A recent ICA was available in 33 study patients. This
includes 10 of the 14 patients with discordant
viability patterns between NC and CTAC. Ten
patients with ICA presented an indication for revas-
cularization (mismatch pattern) by using NC but
normal pattern when applying CTAC, all in the RCA
territory. The ICA largely supported the CTAC
findings, as 4 angiographies presented no coronary
lesions, 2 had an intermediate stenosis and only 4 had
a severe stenosis which was however collateralized
(grade III according to Rentrop [14]).
Discussion
Our study is the first to report on the impact of the
recently introduced CTAC for SPECT MPI on the
Fig. 2 Patterns of myocardial viability evaluated by SPECT
MPI/PET FDG using NC and CTAC
Int J Cardiovasc Imaging (2011) 27:913–921 917
123
interpretation of viability based on the flow-metab-
olism mismatch pattern. This is important because
strong evidence exists from a large body of literature
including mainly retrospective [15] but also recent
prospective studies [16] that proof of viability prior to
revascularization is a major determinant of improved
outcome for patients with dysfunctional myocardium
in the setting of CAD.
Although there are many different nuclear tech-
niques for viability evaluation including optimized
protocols with nitrates enhancement [17, 18], PET
FDG has been established as the most sensitive
method to discriminate preserved viability from scar.
Nevertheless this technique has been hampered by the
large variability of viability definition used in differ-
ent studies. After recognising the importance of
standardization by use of oral glucose load or
hyperinsulinemic euglycemic clamp, major differ-
ences have remained between studies reporting FDG-
only versus those corrected for the large individual
and regional variations in cardiac glucose utilisation
by normalization to perfusion or contractility [19–21].
Normalization of FDG to MPI is the most widely
accepted method because it enables the identification
of regions with flow impairment but preserved
viability, which are the ideal targets for revascular-
ization, while regions of preserved flow are used as
reference for normal metabolism in the FDG study.
Fig. 3 In this illustrative example there were mild (yellow)
perfusion defects on SPECT MPI in the LAD and RCA
territory extending from basal anterior and septal to the inferior
segments using NC (upper row). After CTAC (lower row)
there was no inferior and an additional apical defect was
observed. The metabolic uptake on PET FDG was preserved
(normal uptake, green) in all segments for both NC and CTAC.
The third panel shows the impact of CTAC on the viability
pattern: the most striking effect is that the CTAC results in a
decrease in the number of segments with mismatch (yellow)
from 4 to 1. As a consequence, the decision to revascularize
would be changed towards conservative treatment. In addition,
the allocation of mild match changes from inferior to septal and
apical segments. NC no attenuation correction, CTAC CT
attenuation correction, MPI myocardial perfusion imaging,
LAD territory = segments 1, 2, 7, 8, 13, 14, 17, CX
territory = segments 5, 6, 11, 12, 16, RCA territory = seg-
ments 3, 4, 9, 10, 15
Table 3 Viability pattern with no correction of attenuation
(NC) and CT attenuation correction (CTAC)
Territory (%
of segments)
Patterns of viability
Normal
(%)
Mismatch
(%)
Mild match
(%)
Scar
(%)
ALL
NC 59 19 16 6
CTAC 71 11 14 4
LAD
NC 66 13 14 7
CTAC 66 14 14 6
CX
NC 74 10 13 3
CTAC 82 5 12 1
RCA
NC 34 36 21 9
CTAC 66* 13* 16 5
ALL all segments, LAD left anterior descending artery, CX
circumflex artery, RCA right coronary artery, NC no
attenuation correction, CTAC CT attenuation correction.
* P \ 0.001 versus NC
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SPECT MPI is more widely available than PET MPI
and is equally accurate in conjunction with PET FDG
for the prediction of functional recovery of dysfunc-
tional segments, symptoms of heart failure and
improved survival [19, 20]. Vom Dahl et al. [12]
evaluated 161 patients for viability by 99mTc-sestam-
ibi SPECT MPI and PET FDG and noted after
revascularization a significant improvement in global
and regional left ventricular function predominantly
in patients with mismatch on flow-metabolism pattern
whereas those with mild-match and scar tissue did
mostly not improve. These results were confirmed by
other studies using 99mTc-tetrofosmin SPECT empha-
sizing the prognostic role of combined 99mTc-tetro-
fosmin SPECT MPI/PET FDG in patients with CAD
and chronic dysfunctional left ventricular myocar-
dium [22]. However, SPECT MPI can be affected by
soft tissue attenuation which not only impairs accu-
racy to detect ischemia but also may overestimate the
flow-metabolism mismatch when it is used in
conjunction with PET FDG for viability assessment.
Recently, CTAC has been established as a tool to
improve the accuracy of SPECT MPI for assessing
ischemic heart disease by correcting non-uniform
attenuation of soft tissue [3, 4]. This improvement in
accuracy is to a great proportion due to successful
correction of attenuation artifacts, often located in the
RCA territory. Similarly, CTAC has been shown to
be helpful in discriminating artifacts due to left
bundle branch block from true ischemia [23]. After
applying CTAC in our study, the proportion of
segments with perfusion defects having less than 70%
and less than 50% uptake decreased by 28 and 49%,
respectively. This had a substantial impact on the
interpretation of viability pattern, as 25% of segments
originally classified as scar were reclassified and the
amount of normal segments increased by 20%. More
importantly there was a 42% decrease in dysfunc-
tional segments with mismatch pattern representing
hibernating myocardium. These segments are gener-
ally considered to have the greatest potential of
functional recovery after revascularisation and there-
fore qualify for such procedure. This indicates that
the use of CTAC for SPECT MPI in conjunction with
PET FDG may have a profound impact on the
decision towards revascularization.
Because only patients with sufficient amount of
viable myocardium benefit from revascularization
procedures, accurate assessment of viable tissue but
also correct location of the jeopardized myocardium
is crucial. Inaccurate viability interpretation may
either falsely deny the patient an appropriate revas-
cularization, or expose patients with advanced coro-
nary disease unnecessarily to increased risk of
revascularization without predictable benefits [24–
26]. When taking three viable segments (18% of the
left ventricle), as threshold to indicate revasculariza-
tion, the use of CTAC in our study decreased by 54%
the number of patients suitable for revascularization.
A threshold to three segments seems reasonable and
is supported by previous studies testing viability
before revascularization with the endpoint of
improved left ventricular ejection fraction [13, 27].
In line with the literature, variability of MPI findings
was largest in the inferior segments, most probably
due to attenuation artifacts which were successfully
corrected by CTAC. Consequently, the most prom-
inent differences in viability interpretations between
NC and CTAC were observed in the RCA territory,
where CTAC resulted in a greater number of normal
segments while the number of mismatch segments
decreased [3, 4].
In the CX territory, the incidence of segments with
mismatch patterns was unaffected while the specific
location of the different viability patterns was subject
to large variability after CTAC as reflected by the
modest agreement in viability pattern between NC
and CTAC. This may trigger revascularization of
different target vessel branches, potentially jeopar-
dizing the clinical benefit of the procedure.
Study limitations
A limitation of our study is the fact that we did not
use glucose-insulin clamp or acipimox as a mean to
optimize the quality of FDG uptake. It may also be
perceived as a limitation of the present study that we
did not assess the impact of CTAC on the prediction
of outcome, particularly because most outcome data
rely on studies on the pre-AC era. This, however, was
beyond the scope of the present study. Nevertheless,
as CTAC has repeatedly been shown to improve
accuracy of MPI it appears appropriate, although still
hypothetic, to assume that this may have the potential
to translate into improved viability assessment. This
is also supported by small retrospective previous
studies using line source based AC before introduc-
tion of CTAC [28, 29] but remains to be elucidated in
Int J Cardiovasc Imaging (2011) 27:913–921 919
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prospective studies using CTAC. Furthermore, it
should be mentioned that information from gated
SPECT and from the stress perfusion study were not
incorporated into the analysis of viability. Both might
have diminished the differences in viability assess-
ment between NC and AC studies, although stress
perfusion is not routinely incorporated into myocar-
dial viability assessment. Although one could claim
that the present study lacks a firm gold standard, the
results from the ICA largely support the findings of
CTAC. Finally, the use of CTAC adds radiation
exposure to the patient. Compared to the total
effective radiation dose from PET FDG (8 mSV)
and 99mTc-tetrofosmin SPECT (10 mSV), the contri-
bution of CTAC (1 mSV) accounts for approximately
5%. One single CTAC scan may be used for AC of
both SPECT and PET, thus avoiding additional
radiation dose.
Clinical implication
When evaluating patients with dysfunctional myo-
cardium for possible revascularization, the use of
CTAC may have a profound impact on the interpre-
tation with regard to presence or absence, location of
viable tissue.
Conclusion
Different interpretation of myocardial viability can be
observed when using CTAC instead of NC SPECT
MPI as reference for PET FDG scans. Whether this
would have an impact on the prognostic accuracy
requires further careful prospective investigation.
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